STRAZZABOSCO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 22.696
EU - Europa 9.506
AS - Asia 4.960
SA - Sud America 380
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 18
Totale 37.644
Nazione #
US - Stati Uniti d'America 22.313
SG - Singapore 1.947
RU - Federazione Russa 1.643
CN - Cina 1.589
SE - Svezia 1.557
IT - Italia 1.269
DE - Germania 1.249
IE - Irlanda 1.240
UA - Ucraina 1.124
HK - Hong Kong 815
GB - Regno Unito 530
CA - Canada 370
BR - Brasile 332
FI - Finlandia 287
FR - Francia 157
VN - Vietnam 143
IN - India 130
DK - Danimarca 103
AT - Austria 101
TR - Turchia 99
NL - Olanda 84
BE - Belgio 45
ID - Indonesia 37
JP - Giappone 35
EU - Europa 27
KR - Corea 26
ZA - Sudafrica 25
BG - Bulgaria 23
IR - Iran 22
TW - Taiwan 21
AR - Argentina 16
CZ - Repubblica Ceca 16
ES - Italia 16
BD - Bangladesh 13
PK - Pakistan 12
CH - Svizzera 11
AU - Australia 10
IQ - Iraq 10
RO - Romania 10
CO - Colombia 9
PH - Filippine 9
MX - Messico 8
MY - Malesia 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
CL - Cile 7
EC - Ecuador 7
MA - Marocco 7
PL - Polonia 7
UZ - Uzbekistan 7
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
JO - Giordania 4
MM - Myanmar 4
PT - Portogallo 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
OM - Oman 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
MU - Mauritius 2
PE - Perù 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
A1 - Anonimo 1
BH - Bahrain 1
BY - Bielorussia 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
Totale 37.644
Città #
Ann Arbor 3.259
Woodbridge 2.788
Fairfield 2.114
Houston 1.895
Chandler 1.334
Ashburn 1.244
Singapore 1.223
Jacksonville 1.212
Dublin 1.204
Wilmington 992
Seattle 870
Frankfurt am Main 807
Hong Kong 797
Cambridge 769
Dearborn 556
New York 552
Princeton 534
Santa Clara 394
Milan 382
Nanjing 290
Lawrence 228
Altamura 204
Lachine 197
Shanghai 178
Beijing 175
San Diego 128
Council Bluffs 116
Boardman 108
Guangzhou 88
Shenyang 82
Vienna 82
Andover 76
Nanchang 72
Toronto 69
Helsinki 68
Hebei 63
Ottawa 62
Moscow 61
Falls Church 57
Changsha 53
Hangzhou 52
Jiaxing 50
Tianjin 50
Norwalk 48
Dong Ket 47
Mountain View 45
London 44
Fremont 43
Philadelphia 41
Jinan 38
Los Angeles 37
Brussels 36
Huizen 36
Jakarta 35
Kunming 34
Nuremberg 32
Rome 32
Lissone 29
Redmond 29
Zhengzhou 29
Chicago 28
Pune 26
San Mateo 26
Ningbo 22
Auburn Hills 21
Plovdiv 20
São Paulo 20
Leawood 19
Taizhou 18
Boston 16
Padova 16
Rio de Janeiro 16
Tappahannock 16
Washington 16
Edmonton 15
Hefei 15
Nürnberg 15
Munich 14
Bologna 13
Fuzhou 13
Montréal 13
Bonndorf 12
Detroit 12
Kilburn 12
Dallas 11
Kiev 11
University Park 11
Belo Horizonte 10
Brasília 10
Hounslow 10
New Haven 10
Dhaka 9
Düsseldorf 9
Tokyo 9
Auckland 8
Brno 8
Kuala Lumpur 8
Lanzhou 8
Old Lyme 8
Wuhan 8
Totale 26.732
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 499
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 395
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 365
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 318
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 267
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 260
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 251
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 232
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 229
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 223
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 215
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 214
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 214
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 210
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 210
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 207
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 207
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 206
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 202
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 200
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 198
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 197
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 197
Health Related Quality of Life in the Major Liver Conditions 196
Health related quality of life in chronic liver diseases 196
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 195
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 195
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 195
The impact of liver disease on the health-related quality of life 192
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 191
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 191
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 189
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 188
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 188
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 187
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 185
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 184
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 184
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 184
Cholangiocyte biology as relevant to cystic liver diseases 183
Foxa1 and Foxa2 regulate bile duct development in mice 182
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 182
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 179
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 179
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 178
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 178
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 177
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice 176
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 176
The challenges of primary biliary cholangitis: What is new and what needs to be done 176
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 175
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 174
Liver-allocation policies for patients affected by HCC in Europe 173
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 173
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 172
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 172
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 171
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 170
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 170
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 169
Vascular biology of the biliary epithelium 168
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 167
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 167
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 167
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 166
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 165
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 165
Models of The Impact of Major Liver Diseases on Eq-5d Visual Analogue Scale and Utility-Index: Convergences and Divergences 165
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 164
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 164
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 164
The cholangiopathies: disorders of biliary epithelia 163
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 163
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 163
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 163
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 162
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 162
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 161
Notch signaling and new therapeutic options in liver disease 161
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 161
Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes. 160
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 160
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 160
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 159
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 158
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 158
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 158
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 158
Functional anatomy of normal bile ducts 157
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 157
Intracellular pH regulation in isolated rat bile duct epithelial cells 156
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 156
Animal models of cholestasis: An update on inflammatory cholangiopathies 156
Proinflammatory cytokines inhibit secretion in rat bile duct epithelium 155
Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery 155
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 155
Emerging concepts in biliary repair and fibrosis 155
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 154
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 154
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 153
Totale 18.856
Categoria #
all - tutte 139.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020521 0 0 0 0 0 0 0 0 0 0 400 121
2020/20214.303 369 357 442 453 331 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20256.289 551 1.073 423 324 775 275 522 405 757 1.178 6 0
Totale 38.647